The proposed Comparative Medicine and Pathology training program is a five-year program that is designed to provide state-of-the-art research training to veterinarians. Three years of support is requested for two trainees in year one, three trainees in years two through four, and five trainees in year five. It is anticipated that the majority of these individuals will have completed a residency in medicine, surgery, or pathology prior to entering the training program. Selection criteria will include 1) academic credentials and performance during their clinical training/residency; 2) strong interest in research and a desire for a career in academic veterinary medicine; and 3) desirable personal characteristics, including integrity, perseverance, and communications skills. The training program will be located in the College of Veterinary Medicine at the University of Minnesota. Sixteen faculty mentors, all members of the Molecular Veterinary Biosciences (MVB) graduate program, will participate in the training program and represent a diverse group of disciplines, including pharmacology, cell biology, infectious disease, neurobiology, physiology, genetics, molecular biology, and orthopedics. Trainees without a Ph.D. degree will pursue a Ph.D. in the MVB graduate program, a well-organized, multidisciplinary graduate program that was created to focus graduate education efforts by faculty interested in comparative biomedical sciences and molecular mechanisms responsible for human and animal health and disease. The goal of the MVB Graduate Program is to provide students with a sufficient broad based knowledge, quality communication skills, and advanced research training essential for a career as an independent investigator. Trainees who enter the program with a Ph.D. will focus on further developing their research and grant-writing skills.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Institutional National Research Service Award (T32)
Project #
5T32RR018719-02
Application #
6805109
Study Section
Special Emphasis Panel (ZRR1-CM-5 (01))
Program Officer
Watson, William T
Project Start
2003-09-30
Project End
2008-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
2
Fiscal Year
2004
Total Cost
$183,531
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Veterinary Sciences
Type
Schools of Veterinary Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Robinson, Sally R; Rahe, Michael C; Gray, Diem K et al. (2018) Porcine reproductive and respiratory syndrome virus neutralizing antibodies provide in vivo cross-protection to PRRSV1 and PRRSV2 viral challenge. Virus Res 248:13-23
Ekenstedt, Kari J; Becker, Doreen; Minor, Katie M et al. (2014) An ARHGEF10 deletion is highly associated with a juvenile-onset inherited polyneuropathy in Leonberger and Saint Bernard dogs. PLoS Genet 10:e1004635
Fairbanks, Carolyn A; Peterson, Cristina D; Speltz, Rebecca H et al. (2014) The VGF-derived peptide TLQP-21 contributes to inflammatory and nerve injury-induced hypersensitivity. Pain 155:1229-37
Kim, Jong-Hyuk; Frantz, Aric M; Anderson, Katie L et al. (2014) Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironment. Exp Cell Res 323:155-64
Schuster, D J; Dykstra, J A; Riedl, M S et al. (2013) Visualization of spinal afferent innervation in the mouse colon by AAV8-mediated GFP expression. Neurogastroenterol Motil 25:e89-100
Robinson, Sally R; Abrahante, Juan E; Johnson, Craig R et al. (2013) Purifying selection in porcine reproductive and respiratory syndrome virus ORF5a protein influences variation in envelope glycoprotein 5 glycosylation. Infect Genet Evol 20:362-8
Boyce, M K; Trumble, T N; Carlson, C S et al. (2013) Non-terminal animal model of post-traumatic osteoarthritis induced by acute joint injury. Osteoarthritis Cartilage 21:746-55
Robinson, Sally R; Figueiredo, Marina C; Abrahante, Juan E et al. (2013) Immune response to ORF5a protein immunization is not protective against porcine reproductive and respiratory syndrome virus infection. Vet Microbiol 164:281-5
Greggs 3rd, Willie M; Clouser, Christine L; Patterson, Steven E et al. (2012) Discovery of drugs that possess activity against feline leukemia virus. J Gen Virol 93:900-5
Greggs 3rd, Willie M; Clouser, Christine L; Patterson, Steven E et al. (2011) Broadening the use of antiretroviral therapy: the case for feline leukemia virus. Ther Clin Risk Manag 7:115-22

Showing the most recent 10 out of 17 publications